titlesubmit dateissue date
Now showing items 1-14 of 14
AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses.
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.
c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
Combination of single-photon emission computed tomography and magnetic resonance imaging to track 111in-oxine-labeled human mesenchymal stem cells in neuroblastoma-bearing mice.
Dopamine mobilizes mesenchymal progenitor cells through D2-class receptors and their PI3K/AKT pathway.
Enrichment of neural-related genes in human mesenchymal stem cells from neuroblastoma patients.
H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells.
Humoral responses to SARS-CoV-2 by healthy and sick dogs during the COVID-19 pandemic in Spain.
Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model
Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease.
Remission of Spontaneous Canine Tumors after Systemic Cellular Viroimmunotherapy.
RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models.
Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma.